Navigation Links
Publication Addresses Misconceptions About Emergency Contraception
Date:3/27/2008

MONTVALE, N.J., March 27 /PRNewswire/ -- The approval of an emergency contraceptive with over-the-counter access for individuals aged 18 years and older provides another option for preventing unintended pregnancy. However, many patients are uninformed or misinformed about how emergency contraception works and when they may need it. Clinicians should to be able to address these questions and proactively counsel patients about their risk of pregnancy.

To address this issue, OBG Management and The Journal of Family Practice have collaborated to publish "Emergency contraception: When and how to use it," distributed as a supplement to the February 2008 issues.

This publication provides clinicians with valuable information about emergency contraception. A handout sheet for patients was included to reinforce clinical counseling efforts. The publication highlights effective strategies for collaboration between clinicians and pharmacists to promote access to emergency contraception.

Supplement co-author Joseph S. Sanfilippo, MD, MBA, remarked on the relevance of this material, in light of the recent report from the CDC that shows an increased incidence of teen pregnancy: "Emergency contraception will avert the problems intrinsic to conception in this age group. Studies show that teen education about Plan B is not associated with any increase in incidence of teen sexual activity."

OBG Management, a peer-reviewed journal distributed to 40,000 ob/gyns, and The Journal of Family Practice, a peer-reviewed journal distributed to 96,000 primary care physicians, have developed this supplement under a grant from Duramed Pharmaceuticals, Inc.

Physicians can access this supplement on http://www.obgmanagement.com and on http://www.jfponline.com. Nurse practitioners and physician assistants can find this publication at

SOURCE The Journal of Family Practice; OBG Management
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Oncolytics Biotech Inc. Announces Publication of Research on Immune Response to REOLYSIN(R) during a Phase I Clinical Trial
2. Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
3. Ortho Biotech Statement On JAMA Publication Regarding Erythropoiesis-Stimulating Agents
4. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy
5. BioTrends Releases Fourth Annual Nephrology TreatmentTrends Publication Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
6. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Cyclophosphamide Treatment
7. Research by Case Western Reserve University, VA earns cover of prestigious science publication
8. Kendle Named Best CRO for Second Consecutive Year by Leading Global Pharmaceutical Publication Scrip
9. ThromboGenics and BioInvent Announce Publication of Exciting Data on a Novel Class of Angiogenesis Inhibitors in Cell
10. Industry Executives Finding Value in Shift of Scientific Publications
11. Amarin Announces Publication of Pre-Clinical Memory Data in Journal of Neurochemistry

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...0 The Michael J. Fox Fo...ounced $1.5 million in total awards to six researc...ifying therapies for Parkinson,s disease. The fund...g Discovery for Parkinson,s Disease program, made...YSE: ELN ), a neuroscience-based biotechnology c...
(Date:11/30/2009)...ovember 30 Biopharmaceutical compa...tients have been enrolled in its,multinational reg...is,designed to show reduction in transplant relate...geneic stem cell transplantation with a mismatched...eligible for an allogeneic,stem cell transplantati...
(Date:11/30/2009)...Nov. 30 Novavax, Inc. (N...rollment in the Phase II clinical study of its tri...trains) VLP vaccine candidate in healthy adults 60...mized, double-blind, active-controlled study is co...y of two different doses (15 mcg and 60 mcg) of No...
(Date:11/30/2009)...v. 30 Cell Therapeutics,... that its new class of platinum-based anti-tumor c...ronger anti-tumor potency and activity compared to...ell as the ability to overcome cisplatin-resistanc...d in a paper titled "Novel Bis-platinum Complexes ...
Breaking Biology Technology:The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3
... based in Boston,MA, is pleased to announce the sa...hcare, a unit of General Electric Company (NYSE: ...ps and manufactures,microcalorimeters that provide...d binding properties of a wide range of biomolecul...ibodies. The growing trend towards,structure-based...
...ced a,multi-year agreement with Metabolon for bioc... Syngenta technical toolkit for its seeds research...searchers, understanding,of plants, response to en...s earlier in the development cycle., "Biochemical...ta,s,focused program to apply the full range of cu...
...ssist 5™ Pediatric VAD will be introduced fo...eting of the International Society for Rotary Bloo... HOUSTON (Business Wire EON) Sept...s the only pediatric ventricular assist device (VA...p and support by Dr. Michael DeBakey. It is the on...
Other Biology Technology:Riverside Partners Sells MicroCal to GE Healthcare 2Riverside Partners Sells MicroCal to GE Healthcare 3Syngenta and Metabolon Inc. in Collaborative Research Agreement for Biochemical Profiling Technology 2 The Modern DeBakey VAD™ To Be Introduced For the First Time in the U.S. : HeartAssist 5™ Pediatric VAD Features Industry Exclusive Direct Blood Flow Measurement System 2 The Modern DeBakey VAD™ To Be Introduced For the First Time in the U.S. : HeartAssist 5™ Pediatric VAD Features Industry Exclusive Direct Blood Flow Measurement System 3
(Date:11/30/2009)...ntists are presented with the complex challenge of... paper published in Insect Conservation and Diver...l Rodriguez assess this challenge. , Twentieth-C...has already affected the Earth,s biota and now the...y biologists is to predict how biological impacts ...
(Date:11/30/2009)...ber 2009 print issue of The FASEB Journal could ...r fertility that women have had since the 1960s. T...androgenic hormones work in the testis to control ...pens a promising avenue for the development of "th... those who cannot have children because of low spe...
(Date:11/26/2009)...r have been caught in the hunters, sights for gene...ecorative. They are lethal weapons that stags cras...iversity of York, UK, has been intrigued by the me...y and has become fascinated by the mechanical prop...tion with Tomas Landete-Castillejos at the Univers...
Breaking Biology News(10 mins):How can scientists measure evolutionary responses to climate change? 2Tough yet stiff deer antler is materials scientist's dream 2Microbix Biosystems Re files Annual Results With OSC 14756 1DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009 6064 1Prevention experts urge modification to 2009 H1N1 guidance for health care workers 60874 1Prevention experts urge modification to 2009 H1N1 guidance for health care workers 60874 2
...ight think that stocking the Great Lakes with thin...ring gull. The birds often eat from the water, so...d mean better dining. But a new report published ...Society of America says that the addition of speci... not been good for the birds, demonstrating that f...
...NGTON -- A new NASA-led study shows human-caused c...f Earth,s natural systems, including permafrost th...lakes declining in productivity in Africa. , Cyn...ace Science in New York and scientists at 10 other...impacts since 1970 with rises in temperatures duri...
...dy led by Dr. Ann F. Jacobson, associate professor...asons why people may initially choose to postpone ...ery and emphasizes the need for better patient edu...study sought to better understand patients pre-and...ement surgery, says Jacobson. These patients persp...
Other Biology News:Restoring fish populations leads to tough choice for Great Lakes Gulls 2NASA study links Earth impacts to human-caused climate change 2Research examines factors in delaying or declining total knee replacement surgery 2
... The Rapid-Screen cDNA Library Panels were designe...ree sets of PCRs to identify the desired cDNA clon...l "Master Plate," where each well contains plasmid...tive well(s) by gel electrophoresis of the reactio...
... Idaho Technologys R.A.P.I.D. System (Ruggedized A...d, real-time, PCR thermocycler designed for field ...ironments. In addition to its ruggedness, it is de...e LightCycler instrument. By taking advantage of t...
... The Rapid-Screen cDNA Library Panels were designe...ree sets of PCRs to identify the desired cDNA clon...l "Master Plate," where each well contains plasmid...tive well(s) by gel electrophoresis of the reactio...
Ribonucleic acid, transfer from baker's yeast (S. cerevisiae) from Sigma-Aldrich
Biology Products: